Respiratory Disease: Page 3

Could a 5th 'vital sign' curb the spread of COVID-19?
By Kate Madden Yee
A typical patient evaluation includes an assessment of temperature, heart rate, respiratory rate, and blood pressure. But in the context of COVID-19, adding travel history is key, wrote a research pair led by Dr. Trish Perl, chief of the division of infectious diseases at the University of Texas Southwestern Medical Center.
March 2, 2020
2019 04 23 23 05 9200 Question Mark Blue 400
FDA lets labs move ahead on in-house coronavirus tests
By Brian Casey
The FDA had already granted emergency use authorization (EUA) to labs to use a diagnostic assay developed by the U.S. Centers for Disease Control and Prevention (CDC) to detect SARS-CoV-2, which causes the respiratory illness COVID-19. But many health authorities have complained that the CDC test is not being supplied in enough volume to meet rapidly growing needs across the country to test individuals who may have been exposed to the virus.
February 28, 2020
2019 02 13 19 24 5396 Fda Logo V2 400
Pinpoint teams with Analog Devices on infectious disease testing
By LabPulse.com staff writers
The two companies plan to combine Pinpoint's nanosensors with the advanced fabrication capabilities of Analog Devices to develop low-cost, handheld diagnostics, with results in less than a minute.
February 24, 2020
2019 04 24 17 43 1766 Hands Shaking2 400
Covaris releases viral RNA extraction kits
By LabPulse.com staff writers
The kits are designed for nasal or throat swab sample collection devices. One of the products is the truXtrac viral RNA extraction kit, which uses Puritan medical swabs. The other product, the truXtrac-PCR direct viral RNA extraction kit, can be used with real-time reverse transcription polymerase chain reaction (RT-PCR) tests with no need for prior purification.
February 17, 2020
2020 02 18 19 50 1406 Rna Strand 400
CDC launches coronavirus surveillance, testing at 5 U.S. labs
By LabPulse.com staff writers
Surveillance for the coronavirus will be conducted through the CDC's established network for monitoring influenza and will involve testing people with flu-like symptoms for SARS-CoV-2, the coronavirus that originated in Wuhan, China. The virus was previously known as 2019-nCoV.
February 13, 2020
2020 02 15 00 20 7605 Virus Coronavirus Microscope Cdc 400
CDC wrestles with coronavirus test problems in states
By Emily Hayes
Test kits have been provided to qualified labs in the U.S., including state and local public health laboratories, through the CDC's International Reagent Resource, following the issuance of an emergency use authorization by the Food and Drug Administration. The plan was that each lab requesting the test would get one diagnostic panel, which could test 700 to 800 specimens.
February 11, 2020
2020 02 13 00 46 1903 2020 02 12 Coronavirus Test Kit 20200213002523
CDC confirms 2nd case of coronavirus in U.S.
By LabPulse.com staff writers
The infection was discovered in a person in Illinois who traveled to the U.S. from Wuhan on January 13. A few days later, the person called a healthcare provider after experiencing symptoms. The patient is in stable condition in a hospital isolation room and is doing well, according to the CDC.
January 23, 2020
2020 01 24 19 58 6949 Crowd Leader 400
Smartphones double as point-of-care diagnostics
By Joseph Constance
The technical capabilities of these phones have become so advanced that they can compete with technology once thought to be only the domain of physicians' offices and hospitals. Research groups and startup companies are developing apps and technology that turn smartphones into tools that can diagnose eye disease, perform home-based urinalysis, diagnose ear infections and respiratory disease, and help women learn about their reproductive health.
December 1, 2019
2019 12 01 00 02 8839 Remidio Field Use 20191201002201
Previous Page
Page 3 of 3